Seizing over the Conundrums of SAH Seizure Prophylaxis

Abstract

Aneurysmal subarachnoid hemorrhage (SAH), a potentially catastrophic stroke, which occurs at a relatively younger age (median 55 years), afflicts over 30,000 patients a year in the USA. It accounts for 3% to 5% of all strokes and 4.4% of deaths from stroke belong to this group of patients. It carries high rate of morbidity (25%) and case fatality (35%) in most series.